| Date Filed | Type | Description |
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results|
Docs:
|
"Shockwave Medical Reports Second Quarter 2023 Financial Results SANTA CLARA, Calif., Aug. 07, 2023 -- Shockwave Medical, Inc. , a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended June 30, 2023. Recent Highlights Recognized revenue of $180.2 million for the second quarter of 2023, representing an increase of 49% from the same period in 2022 As part of the Fiscal Year 2024 Medicare Hospital Inpatient Prospective Payment System final rule, the Centers for Medicare & Medicaid Services created three new coronary IVL-specific MS-DRGs, which will become effective October 1, 2023. These new codes are associated with higher payments than the MS-DRG payments for o..." |
|
| 07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/26/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/17/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
8-K
| Quarterly results|
Docs:
|
"Shockwave Medical Reports First Quarter 2023 Financial Results SANTA CLARA, Calif., May 08, 2023 -- Shockwave Medical, Inc. , a pioneer in the development and commercialization of Intravascular Lithotripsy to treat complex calcified cardiovascular disease, today reported financial results for the three months ended March 31, 2023. Recent Highlights Recognized revenue of $161.1 million for the first quarter of 2023, representing an increase of 72% from the same period in 2022 Announced the full U.S. commercial availability of the Shockwave L 6 Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration Centers for Medicare & Medicaid Services , as part of the calendar year 2024 Medicare Hospital Inpatient Prospective Payment System proposed rule, proposed three newl..." |
|
| 04/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/21/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/21/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/27/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/14/2023 |
5
| MOLL FREDERIC H (Director) has filed a Form 5 on Shockwave Medical, Inc. |
| 02/14/2023 |
5
| FRANCIS LAURA (Director) has filed a Form 5 on Shockwave Medical, Inc. |
| 02/14/2023 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 2.8% stake in SHOCKWAVE MEDICAL INC |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 8.5% stake in SHOCKWAVE MEDICAL INC |
| 01/23/2023 |
SC 13G/A
| BlackRock Inc. reports a 12.7% stake in ShockWave Medical, Inc. |
|